Yale Cancer Center

https://www.yalecancercenter.org/

 

Yale Cancer Center
H

Consolidation IO Following CRT in Stage III NSCLC

By Yale Cancer Center FEATURING Henry Park
By Yale Cancer Center FEATURING Henry Park
247 views
March 17, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

20:25
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter
Lung
13:21
Yale Cancer Center

Navigating the Terrain: Recent Treatment Strategies for EGFRm Advanc…

Feat. A. Nassar
09:28
Yale Cancer Center

The Future of Lung Cancer Care

Feat. M. Davies
20:27
Yale Cancer Center

Progress in the Treatment of NSCLC

Feat. R. Herbst
19:16
Yale Cancer Center

Treatment Approach to ROS1 Rearranged NSCLC

Feat. M. Grant
14:45
Yale Cancer Center

KRAS G12C NSCLC Treatment Approach: Surveying OS Data, CNS Activity,…

Feat. A. Nassar
01:42
ecancer

ASCO® 2023 Insights: "Dr. Roy Herbst on ADAURA Trial OS Analysi…

Feat. R. Herbst
12:40
Yale Cancer Center

Consolidation IO Following CRT in Stage III NSCLC

Feat. H. Park
35:51
Yale Cancer Center

Advancements in NSCLC: Multidisciplinary Case Panel Discussion

Feat. S. Benaderet, M. Cohenuram, S. Goldberg, V. Mase Jr, D. Rudolph
13:44
Yale Cancer Center

Yale Cancer Center on Lung Cancer Screening

Feat. J. Blasberg
14:27
Yale Cancer Center

Yale Cancer Center on Lung Cancer Screening: Nurse Perspective

Feat. E. Kopas
10:02
i3 Health

2021 ES-SCLC Updates: Enhancing the Clinical Outcomes With Novel The…

Feat. A. Chiang
09:41
Yale Cancer Center

2020 Advances in Lung Cancer: What Are the Biggest NSCLC IO Advantag…

Feat. A. Chiang
07:08
Yale Cancer Center

Advances in Targeted Therapy for NSCLC: What Is the Importance of Bi…

Feat. A. Chiang
14:03
Yale Cancer Center

ESMO 2019 Updated IMpower110 Trial Results: With Consistent OS/PFS I…

Feat. R. Herbst